Apotex Wants Abbott's Meridia Patent Suit Out Of Del.

Law360, New York (January 14, 2010, 5:28 PM ET) -- Apotex Inc. has asked a federal judge in Delaware to dismiss patent infringement claims brought by Abbott Laboratories Inc. over a generic version of Abbott's weight-loss drug Meridia because the case has no ties to the state.

Abbott has already smacked Apotex with an identical suit in Illinois, which both sides supposedly agree is the right venue, according to Apotex's motion to dismiss the case for lack of personal jurisdiction, filed on Wednesday in the U.S. District Court for the District of Delaware.

ÔÇťApotex Inc. has...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers